|
29 Companies |
|
28 Products |
|
28 Products |
|
27 Mechanisms of Action |
|
0 Trials |
|
447 News |
|
| «12345678910» |
- | Trial completion: A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring (clinicaltrials.gov) - Oct 11, 2012
P1/2, N=19, Completed, Sponsor: Kasiak Research Pvt. Ltd.
Recruiting --> Completed
- | Stelara (ustekinumab) / J&J
New P2 trial: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (clinicaltrials.gov) - Oct 9, 2012
P2, N=20, Active, not recruiting, Sponsor: University Medical Centre Groningen
- |||||||||| New P3 trial: Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne (clinicaltrials.gov) - Oct 2, 2012
P3, N=496, Completed, Sponsor: Valeant Pharmaceuticals International, Inc.
- Enrollment change: Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy (clinicaltrials.gov) - Sep 18, 2012
P=N/A, N=8, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed N=40 --> 8
- Trial completion: Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy (clinicaltrials.gov) - Sep 18, 2012
P=N/A, N=8, Completed, Sponsor: Johns Hopkins University
N=40 --> 8 Recruiting --> Completed
- | New P1 trial, Adverse events: Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne (clinicaltrials.gov) - Sep 6, 2012
P1, N=50, Completed, Sponsor: Medivet Pty Ltd
- Clinical: Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=50, Completed, Sponsor: Home Skinovations Ltd.
- | tazarotene topical / Generic mfg., adapalene / Generic mfg.
Trial termination: Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris (clinicaltrials.gov) - Aug 19, 2012
P4, N=165, Terminated, Sponsor: Allergan
Recruiting --> Completed Completed --> Terminated; Study enrollment was terminated due to company decision before the target enrollment of 220 patients was reached.
- ||||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects (clinicaltrials.gov) - Aug 15, 2012
P3, N=800, Completed, Sponsor: GlaxoSmithKline
Completed --> Terminated; Study enrollment was terminated due to company decision before the target enrollment of 220 patients was reached. Active, not recruiting --> Completed
- Clinical: Safety Study of Plasma Treatment System to Treat Back Acne (clinicaltrials.gov) - Aug 8, 2012
P=N/A, N=12, Recruiting, Sponsor: Moe Medical Devices
- |||| dimethylcurcumin (AJ101) / AnnJi Pharma
Trial completion: Topical ASC-J9 Cream for Acne (clinicaltrials.gov) - Aug 6, 2012
P2, N=181, Completed, Sponsor: AndroScience Corp
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Plant-based Dietary Intervention for Treatment of Acne (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=43, Completed, Sponsor: Physicians Committee for Responsible Medicine
Active, not recruiting --> Completed N=120 --> 43
- Trial completion: Plant-based Dietary Intervention for Treatment of Acne (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=43, Completed, Sponsor: Physicians Committee for Responsible Medicine
N=120 --> 43 Active, not recruiting --> Completed
- New P2 trial: Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne (clinicaltrials.gov) - Aug 1, 2012
P2, N=18, Recruiting, Sponsor: The University of Western Australia
- ||| Trial initiation date: Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - Jul 31, 2012
P1/2, N=157, Completed, Sponsor: M. Arkin 1999 Ltd.
Active, not recruiting --> Completed Initiation date: Jan 2012 --> Jun 2012
- | New P1/2 trial: A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring (clinicaltrials.gov) - Jul 17, 2012
P1/2, N=19, Completed, Sponsor: Kasiak Research Pvt. Ltd.
- |||||||||| Humira (adalimumab) / AbbVie
New P3 trial: PIONEER (OLE): Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa (clinicaltrials.gov) - Jul 8, 2012
P3, N=540, Enrolling by invitation, Sponsor: AbbVie (prior sponsor, Abbott)
- ||||| Seysara (sarecycline) / Paratek, Almirall
New P2 trial: Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris (clinicaltrials.gov) - Jun 24, 2012
P2, N=285, Completed, Sponsor: Warner Chilcott
- Trial completion: 2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne (clinicaltrials.gov) - Jun 16, 2012
P=N/A, N=25, Completed, Sponsor: Chulalongkorn University
Initiation date: Jan 2012 --> Jun 2012 Recruiting --> Completed
- ||| adapalene/benzoyl peroxide / Generic mfg.
Trial completion, Monotherapy, Adherence: TEENA: Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne (clinicaltrials.gov) - Jun 13, 2012
P=N/A, N=3113, Completed, Sponsor: Galderma Laboratorium GmbH
Recruiting --> Completed Active, not recruiting --> Completed
- ||| adapalene/benzoyl peroxide / Generic mfg.
Clinical: ELANG: Long-term Study of Epiduo in Patients With Moderate to Severe Acne (clinicaltrials.gov) - Jun 11, 2012
P=N/A, N=6650, Enrolling by invitation, Sponsor: Galderma Laboratorium GmbH
- | Trial completion: A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris (clinicaltrials.gov) - Jun 6, 2012
P1, N=12, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P4 trial: Efficacy of Handheld Acne Heat Device (clinicaltrials.gov) - Jun 5, 2012
P4, N=20, Suspended, Sponsor: University of British Columbia
- ||||||| Trial completion: Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects (clinicaltrials.gov) - May 23, 2012
P3, N=360, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| drospirenone/ethinyl estradiol / Generic mfg.
Trial completion: Regulatory Post Marketing Surveillance Study on YAZ (clinicaltrials.gov) - May 21, 2012
P=N/A, N=770, Completed, Sponsor: Bayer
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris (clinicaltrials.gov) - May 20, 2012
P2, N=40, Completed, Sponsor: LEO Pharma
Recruiting --> Completed Recruiting --> Completed
- | drospirenone/ethinyl estradiol / Generic mfg.
Enrollment change: Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne (clinicaltrials.gov) - May 15, 2012
P3, N=30, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed N=100 --> 30
- dapsone / Generic mfg., adapalene / Generic mfg.
Trial initiation date: Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne (clinicaltrials.gov) - May 14, 2012
P1, N=0, Withdrawn, Sponsor: Allergan
N=100 --> 30 Initiation date: Oct 2012 --> Jan 2013
- ||| minocycline / Generic mfg.
Trial initiation date: Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - May 7, 2012
P2, N=150, Completed, Sponsor: Foamix Ltd.
Initiation date: Oct 2012 --> Jan 2013 Initiation date: Jul 2011 --> Jan 2012
- |||||||||| New P3 trial: A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne (clinicaltrials.gov) - Apr 23, 2012
P3, N=98, Completed, Sponsor: KLOX Technologies Inc.
- |||| Trial completion: U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne (clinicaltrials.gov) - Apr 18, 2012
P4, N=125, Completed, Sponsor: Stiefel, a GSK Company
Initiation date: Jul 2011 --> Jan 2012 Active, not recruiting --> Completed
- | Trial completion: Evaluation of a Photopneumatic System for the Treatment of Acne (clinicaltrials.gov) - Mar 21, 2012
P=N/A, N=24, Completed, Sponsor: Solta Medical
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=12, Completed, Sponsor: ConBio, a Cynosure Company
Recruiting --> Completed N=10 --> 12
- | Trial completion: Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=12, Completed, Sponsor: ConBio, a Cynosure Company
N=10 --> 12 Active, not recruiting --> Completed
- berdazimer sodium (SB204) / Sato Pharma, Novan
Clinical: Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Mar 13, 2012
P1/2, N=0, Completed, Sponsor: Novan, Inc.
- |||| Trial completion: Estudo Epiduo: Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Mar 8, 2012
P4, N=75, Completed, Sponsor: Galderma Brasil Ltda.
Active, not recruiting --> Completed Not yet recruiting --> Completed
- |||| benzoyl peroxide/clindamycin / Generic mfg., dapsone / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications (clinicaltrials.gov) - Mar 5, 2012
P4, N=53, Completed, Sponsor: Stiefel, a GSK Company
Not yet recruiting --> Completed Active, not recruiting --> Completed
- New P4 trial: The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study (clinicaltrials.gov) - Feb 28, 2012
P4, N=16, Completed, Sponsor: Cairo University
- minocycline / Generic mfg.
Trial termination, Combination therapy: Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin (clinicaltrials.gov) - Feb 21, 2012
P4, N=38, Terminated, Sponsor: Derm Research @ 888 Inc.
Active, not recruiting --> Completed Recruiting --> Terminated; Too much difficulty recruiting and retaining patients, PI decided to stop.
- minocycline / Generic mfg.
Enrollment change, Combination therapy: Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin (clinicaltrials.gov) - Feb 21, 2012
P4, N=38, Terminated, Sponsor: Derm Research @ 888 Inc.
Recruiting --> Terminated; Too much difficulty recruiting and retaining patients, PI decided to stop. N=50 --> 38
- Trial completion: Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris (clinicaltrials.gov) - Feb 14, 2012
P1, N=34, Completed, Sponsor: Miglani, Anjali
N=50 --> 38 Active, not recruiting --> Completed
- |||| Trial completion: A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris (clinicaltrials.gov) - Feb 5, 2012
P2, N=180, Completed, Sponsor: Dow Pharmaceutical Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | New P1 trial: A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris (clinicaltrials.gov) - Feb 2, 2012
P1, N=12, Completed, Sponsor: GlaxoSmithKline
- ||| Enrollment change: Clinical Trial To Evaluate ANT-1207 In Subjects With Acne (clinicaltrials.gov) - Jan 23, 2012
P2, N=72, Completed, Sponsor: Anterios Inc.
Active, not recruiting --> Completed N=60 --> 72
- ||||||| Trial completion: Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne (clinicaltrials.gov) - Jan 22, 2012
P3, N=925, Completed, Sponsor: Cipher Pharmaceuticals Inc.
N=60 --> 72 Active, not recruiting --> Completed
- |||| benzoyl peroxide/clindamycin / Generic mfg., dapsone / Generic mfg.
Trial completion: A Study Comparing Aczone (clinicaltrials.gov) - Jan 18, 2012
P4, N=286, Completed, Sponsor: Allergan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI (clinicaltrials.gov) - Jan 16, 2012
P=N/A, N=20, Completed, Sponsor: ConBio, a Cynosure Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| adapalene/benzoyl peroxide / Generic mfg.
Clinical: A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris (clinicaltrials.gov) - Dec 26, 2011
P=N/A, N=885, Completed, Sponsor: Actavis Mid-Atlantic LLC
- ||||| gevokizumab (VPM087) / Novartis
New P2 trial: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Dec 22, 2011
P2, N=127, Completed, Sponsor: XOMA (US) LLC
- ||||| New P1/2 trial: Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - Dec 14, 2011
P1/2, N=157, Completed, Sponsor: M. Arkin 1999 Ltd.